An EQA scheme for antimicrobial susceptibility testing of Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This EQA scheme has so far shown high levels of inter-laboratory comparability in the presence of differing methodologies.
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
This ECDC Communicable Disease Threats Report covers 18-24 December 2016 and includes updates on Salmonella Stourbridge, type E botulism, hepatitis A, tuberculosis, cholera, influenza, measles, rubella, Legionnaires' disease and the Zika virus.
The external evaluation of the Centre is enshrined in Article 31 of the Founding Regulation (EC) 851/2004 of 21 April 2004. In keeping with the requirements, the Centre has commissioned this external evaluation that covers the period from the Centre’s inception (May 2005) until June 2007.
This core protocol for ECDC studies of vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2 or with influenza, version 2.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with Severe Acute Respiratory Infection (SARI), already published as version 1.0.
This global technical consultation report brings together viewpoints from experts spanning a range of disciplines with the key objective of seeking consensus regarding the terminology used to describe the transmission of pathogens through the air that can potentially cause infection in humans.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 4-10 November 2018 and includes updates on Middle East respiratory syndrome Middle East respiratory syndrome coronavirus (MERS-CoV), measles, influenza, influenza A(H5N6), West Nile virus, Ebola virus disease, dengue and malaria.